Most psychiatric disorders are moderately to highly heritable. The degree to which genetic
variation is unique to individual disorders or shared across disorders is unclear. To examine …

Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting
substantial pleiotropy of contributing loci. However, the nature and mechanisms of these …

Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However, …

Bipolar disorder (BD) is a genetically complex mental illness characterized by severe
oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified …

Genetic risk prediction has several potential applications in medical research and clinical
practice and could be used, for example, to stratify a heterogeneous population of patients by …

Objective The assessment of response to lithium maintenance treatment in bipolar disorder (BD)
is complicated by variable length of treatment, unpredictable clinical course, and often …

Importance Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder
(BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30%…

Lithium is a first-line medication for bipolar disorder (BD), but only one in three patients
respond optimally to the drug. Since evidence shows a strong clinical and genetic overlap …

Background: Telomeres are protective DNA-protein complexes at the ends of each
chromosome, maintained primarily by the enzyme telomerase. Shortening of the blood leukocyte …

Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs
widely between individuals. The molecular mechanisms underlying treatment response …